Abstract P6-16-10: Activity of T-DM1 in HER2-positive breast cancer brain metastases
Rupert Bartsch(Universitätszahnklinik Wien), Matthias Preusser(Medical University of Vienna), A. Galid(Hanusch Hospital), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Anna S. Berghoff(Medical University of Vienna), Guenther G. Steger(Mount Vernon Hospital), Ursula Vogl(Institute of Oncology Research), Elisabeth Bergen(Medical University of Vienna), Karin Dieckmann(University of Vienna), Margaretha Rudas(Comprehensive Cancer Center Vienna), Leopold Oehler, Christoph C. Zielinksi(Medical University of Vienna), Katja Pinker(Medical University of Vienna)
Cited by 3
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k